遵义地区4 604例住院新生儿TORCH感染状况分析

来源期刊：广州医药 | 5-8 发布时间：2022-08-03 收稿时间：2025/11/13 18:19:10 阅读量：10

作者：: 吴佳桃,

邱成楷,

杨钰欣,

李雪平,

袁志美,

关键词：: TORCH 住院新生儿感染率 ALT; TORCH hospitalized newborns infection rate ALT

DOI：: 10.3969/j.issn.1000-8535.2022.04.002

收稿时间：: 2021-07-14
修订日期：
接收日期：
引用总数：: 2

目的了解遵义地区住院新生儿TORCH感染状况、发病率,为相关疾病的早期预防和治疗提供重要参考依据。方法采用回顾性研究方法,对遵义市妇幼保健院2018—2019年住院新生儿弓形虫(TOX)、风疹(RV)、巨细胞(CMV)和单纯疱疹病毒(HSV)Ⅰ型感染结果进行分析。结果遵义地区4 604例住院新生儿TORCH-IgM的总体阳性率为1.35%,其中CMV、TOX、RV、HSV Ⅰ的阳性率分别是1.00%、0.20%、0.13%和0.02%;对应TORCH-IgG的阳性率分别是67.38%、0.91%,54.54%、22.22%。对2018—2019年住院新生儿TORCH感染筛查结果显示:CMV-IgM阳性率分别从1.47%下降到0.43%(χ²=4.981,P=0.026),RV-IgM的阳性率从0.24%下降到0.00(χ²=12.446,P<0.001),差异均有统计学意义。在研究的2 607例男性患儿中,CMV、TOX、RV、HSV Ⅰ的IgM阳性率率分别是0.19%、0.11%、0.96%和0.04%,其IgG的阳性率为1.07%、55.20%、67.93%和22.48%。在研究的1 997例女性患儿中,CMV、TOX、RV、HSV Ⅰ的IgM阳性率分别是0.20%、0.15%、1.05%和0.00%,其IgG的阳性率为0.70%、53.68%、66.65%和21.88%。不同CMV-IgM感染对谷丙转氨酶(ALT)和谷草转氨酶(AST)的活性影响研究中,CMV-IgM抗体阳性对照组的ALT活性高于阴性组(t=-2.793,P<0.05),AST的活性无差异(t=0.067,P>0.05) 结论遵义地区4 604例住院新生儿中以CMV感染率相对较高,不容忽视。2018—2019年CMV和RV的新近感染率呈下降趋势。CMV-IgM的感染能引起ALT活性的升高。

Objective To reveal the TORCH infection status and incidence of hospitalized newborns in Zunyi area, and provide important reference for early prevention and treatment of related diseases. Methods The retrospective research method was used to analyze the infection results of toxoplasma gondii (TOX), rubella virus (RV), cytomegalovirus (CMV) and herpes simplx virus (HSV) type I in hospitalized newborns in Zunyi Maternal and Child Health Hospital from 2018 to 2019. Results The overall positive rate of TORCH-IgM in 4 604 hospitalized newborns in Zunyi area was 1.35%, of which the positive rates of CMV, TOX, RV, and HSV Ⅰ were 1.00%, 0.20%, 0.13% and 0.02%, respectively; the corresponding TORCH-IgG positive rates were 67.38%, 0.91%, 54.54%, 22.22%. The TORCH infection screening results of neonates hospitalized in 2018—2019 showed that the CMV-IgM positive rate decreased from 1.47% to 0.43% (χ²=4.981, P=0.026), and the RV-IgM positive rate decreased from 0.24% to 0.00 (χ²=12.446, P< 0.001), the differences were statistically significant. In 2 607 male children, the IgM positive rates of CMV, TOX, RV and HSVⅠwere 0.19%, 0.11%, 0.96% and 0.04%, respectively; and the corresponding IgG positive rates were 1.07%, 55.20%, 67.93% and 22.48%. In 1 997 female children, the IgM positive rates of CMV, TOX, RV and HSVⅠwere 0.20%, 0.15%, 1.05% and 0.00,respectively; and the corresponding IgG positive rate was 0.70%, 53.68%, 66.65% and 21.88%. In the study of effects of different CMV-IgM infection on alanine aminotransferase(ALT) and aspartate aminotransferase(AST) activity, the ALT activity of CMV-IgM positive group was significantly higher than that of negative group (t=-2.793, P<0.05), and there was no difference in AST activity between the two groups (t=0.067, P>0.05). Conclusions The CMV infection rate among 4 604 hospitalized newborns in Zunyi area was relatively high, which should not be ignored. The recent infection rates of CMV and RV showed a downward trend from 2018 to 2019. CMV-IgM infection could cause an increase in ALT activity.

1、 GUDOWSKA M, GRUSZEWSKA E, PANASIUK A, et al. Selected noninvasive markers in diagnosing liver diseases[J]. Lab Med, 2016, 47(1): 67-72.

2、 GU X, HAN L, CHEN J, et al. Antenatal screening and diagnosis of tuberous sclerosis complex by fetal echocardiography and targeted genomic sequencing [J]. Medicine (Baltimore), 2018, 97(15):e0112.

3、李媛媛, 杨海霞, 沈晓亚. 产前超声检查在妊娠期病原体感染胎儿中的诊断价值[J]. 西部医学, 2018,30(1):124-127.

4、 HUI L, BIANCHI D W. Noninvasive prenatal DNA testing: the vanguard of genomic medicine[J]. Annu Rev Med, 2017, 68(1): 459-472.

5、朱宇宁, 陈雁. 血清学产前筛查的现状与未来展望[J]. 中华检验医学杂志, 2019, 42(7):493-497.

6、张宁, 李奇玉, 李文, 等. 孕前TORCH筛查专家共识[J]. 发育医学电子杂志, 2019, 7(2):81-85.

7、 HILDITCH C, KEIR A K. Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection[J]. Acta Paediatr, 2018, 107(5): 906.

8、杨琼芬, 张惠, 熊萍, 等. 遵义市孕妇TORCH感染血清流行病学监测[J]. 中华流行病学杂志, 2003,24(9):853-853.

9、杨琰琰, 刘功振. 新生儿及婴儿TORCH感染血清学检测分析[J]. 国际检验医学杂志, 2019, 40(8):901-904.

10、刘震忠, 吴凤琪, 闫静, 等. 2015～2016年天津地区新生儿TORCH血清学筛查及感染特点[J]. 现代检验医学杂志, 2017, 32(4):133-136.

11、 CHUNG M H, SHIN C O, LEE J. TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates efficacy study in a single institute in Korea[J]. Korean J Pediatr, 2018, 61(4):114-120.

12、 WEILAND M. A neuropsychological analysis of herpes simplex virus-1 (HSV-1) infection and HSV-1 encephalitis: biological mechanisms, clinical presentations, and brain-body-behavior manifestations [J]. Act Nerv Super, 2018, 60(2): 40-47.

13、 AGHOLI M, SAFAEI A, RAMZI M, et al. A survey of the frequency of cytomegalovirus-associated diarrhea in immunocompromised patients using a non-invasive method[J]. Iran J Microbiol, 2018, 10(2):143-150.

14、 ORENSTEIN W A, HINMAN A, NKOWANE B, et al. Measles and Rubella Global Strategic Plan 2012—2020 midterm review[J]. Vaccine, 2018,36(Suppl 1): A1-A34.

15、 BARTOVA E, SEDLAK K. Toxoplasma gondii and Neospora caninum antibodies in goats in the Czech Republic[J]. Veterinarni Medicina, 2018, 57(3): 111-114.

16、 NAHMIAS A, JOSEY W E, NAIB Z M, et al. Perinatal risk associated with maternal genital herpes simplex virus infection[J]. Am J Obstet Gynecol, 1971, 110(6): 825-837.

1、赖小华,兰小英,王燕凤.厦门市6827例0～14岁患儿TORCH病原体感染状况调查[J].医疗装备,2023,36(03):29-33.

2、刘文亚,魏衍财,朱红胜,等.苏州地区新生儿TORCH感染的血清学分析[J].妇儿健康导刊,2023,2(04):75-77.